Micro Labs has been in a continuous stage of growth ever since its founding years and continues to chart its course as a leader in the pharmaceutical vertical. The company has a presence in over 50 countries with ground-level operations in 25 countries, exporting all major dosages on most of the therapeutic segments. We are poised to have a quantum leap in our global operations, with the implementation of our growth strategies. The company currently operates in various countries of Asia, Europe, America & Africa. Micro Labs has already established a strong presence in the USA, UK, Russia, Ukraine, Nigeria, French West Africa, East Africa, Myanmar, Philippines, Vietnam, Thailand, Sri Lanka, etc. Latin America, North America, East Europe, Australia, New Zealand, and North Africa are locations where the company is raising its flag. We are well dignified to achieve the remarkable status as a "BIG GENERIC COMPANY" in the global pharmaceutical space with our value-based presence.
To complement our vision for global operations, the company has established wholly-owned subsidiaries in the USA (Micro Labs USA Inc.), UK (Brown & Burk UK Ltd), Germany (Micro Labs GmbH), Australia (Micro Labs Pty Ltd), and Nigeria (Micro Nova Pharmaceuticals Ind Ltd). The Company has Representative Offices in many other parts of the world (emerging markets).
At Micro Labs, we are dedicated to developing top-of-the-line pharmaceutical products, while adhering to the highest quality standards by a world-class research team. The continuous strive for perfection has led us to push our standards of manufacturing by building state-of-the-art facilities. Today these state-of-the-art manufacturing facilities and infrastructure facilitate Micro’s Organic Growth in the regulated markets.
Micro Labs has been able to have a successful run abroad because of its world-class manufacturing units. Some of our facilities have been approved by the following regulatory authorities:
Food & Drugs Control Administration (FDA) , US
Medicines & Healthcare products Regulatory Agency (MHRA), UK
World Health Organisation (WHO)
Therapeutic Goods Authority (TGA), Australia
Medsafe, New Zealand
Ministry of Health (MoH) of many countries of the emerging market.